𝔖 Bobbio Scriptorium
✦   LIBER   ✦

G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse

✍ Scribed by Karine Hadaya; Hassen Kared; Annie Masson; Lucienne Chatenoud; Flora Zavala

Book ID
116613906
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
322 KB
Volume
24
Category
Article
ISSN
0896-8411

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Nicotinamide prevents the development of
Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis
✍ O'Brien, Bronwyn A.; Harmon, Brian V.; Cameron, Donald P.; Allan, David J. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 195 KB πŸ‘ 2 views

The development of diabetes in non-obese diabetic (NOD) mice, which normally takes between 3 and 7 months, can be accelerated by cyclophosphamide (CY) injections, with rapid progression to diabetes within only 2Β±3 weeks. This insulin-dependent diabetes mellitus (IDDM) can be prevented or delayed in